New injection for lung and skin conditions passes first safety check
Symptom relief
Completed
This early-stage study tested a new injection called 9MW1911 in 48 healthy adults to see if it is safe and how the body processes it. The drug is being developed for asthma, COPD, and atopic dermatitis (eczema). The study did not treat any disease but focused on finding the right…
Phase: PHASE1 • Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd. • Aim: Symptom relief
Last updated Apr 30, 2026 15:51 UTC